Camel milk inhibits inflammatory angiogenesis via downregulation of proangiogenic and proinflammatory cytokines in mice

APMIS

Volumn 122, Issue 7, 2014, Pages 599-607

  Alhaider, Abdulqader A ^a   Abdel Gader, Abdel Galil M ^a   Almeshaal, Nawaf ^a   Saraswati, Sarita ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Angiogenesis; Camel milk; CD31; Microvessel density; VEGF

Indexed keywords

ACETYLGLUCOSAMINIDASE; COLLAGEN; CYTOKINE; HEMOGLOBIN; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANTIANGIOGENIC ACTIVITY; ARTICLE; CAMEL MILK; CAPILLARY DENSITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; MACROPHAGE; MALE; MILK; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; TISSUE GROWTH;

ANGIOGENESIS; CAMEL MILK; CD31; MICROVESSEL DENSITY; VEGF;

ACETYLGLUCOSAMINIDASE; ANGIOGENESIS INHIBITORS; ANIMALS; CAMELS; CHEMOPREVENTION; COLLAGEN; CYTOKINES; DISEASE MODELS, ANIMAL; HEMOGLOBINS; INFLAMMATION; INTERLEUKIN-17; INTERLEUKIN-1BETA; INTERLEUKIN-6; MACROPHAGES; MALE; MICE; MILK; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NEUTROPHILS; PEROXIDASE; POLYESTERS; POLYURETHANES; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84902768773     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/apm.12199     Document Type: Article

References (43)

1. Albini A, Tosetti F, Benelli R, Noonan DM. Tumor inflammatory angiogenesis and its chemoprevention. Cancer Res 2005;65:10637-41.
2. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
3. Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 2009;30:1073-81.
4. Kontou N, Psaltopoulou T, Panagiotakos D, Dimopoulos MA, Linos A. The mediterranean diet in cancer prevention: a review. J Med Food 2011;14:1065-78.
5. Conesa C, Sanchez L, Rota C, Pérez MD, Calvo M, Farnaud S, et al. Isolation of lactoferrin from milk of different species: calorimetric and antimicrobial studies. Comp Biochem Physiol B 2008;150:131-9.
6. el Agamy EI, Ruppanner R, Ismail A, Champagne CP, Assaf R. Antibacterial and antiviral activity of camel milk protective proteins. J Dairy Res 1992;59:169-75.
7. Korashy HM, El Gendy MA, Alhaider AA, El-Kadi AO. Camel milk modulates the expression of aryl hydrocarbon receptor-regulated genes, Cyp1a1, Nqo1, and Gsta1, in murine hepatoma Hepa 1c1c7 cells. J Biomed Biotechnol 2012;782642.
8. Korashy HM, El Gendy MA, Alhaider AA, El-Kadi AO. Camel milk triggers apoptotic signaling pathways in human hepatoma HepG2 and breast cancer MCF7 cell lines through transcriptional mechanism. J Biomed Biotechnol 2012;593195.
9. Agrawal SS, Saraswati S, Mathur R, Pandey M. Brucine, a plant derived alkaloid inhibits inflammatory angiogenesis in a murine sponge model. Biomed Prev Nutr 2011;1:180-5.
10. Saraswati S, Agarwal SS. Strychnine inhibits inflammatory angiogenesis in mice via down regulation of VEGF, TNF-α and TGF-β. Microvasc Res 2013;87:7-13.
11. Saraswati S, Pandey M, Mathur R, Agrawal SS. Boswellic acid inhibits inflammatory angiogenesis in a murine sponge model. Microvasc Res 2011;82:263-8.
12. Saraswati S, Kanuajia PK, Kumar S, Kumar R, Alhaider AA. Tylophorine, a phenanthraindolizidine alkaloid isolated from Tylophora indica exerts antiangiogenic and antitumor activity by targeting vascular endothelial growth factor receptor 2-mediated angiogenesis. Mol Cancer 2013;12:82.
13. Lage AP, Andrade SP. Assessment of angiogenesis and tumor growth in conscious mice by a fluorimetric method. Microvasc Res 2000;59:278-85.
14. Ferreira MA, Barcelos LS, Teixeira MM, Bakhle YS, Andrade SP. Tumor growth, angiogenesis and inflammation in mice lacking receptors for platelet activating factor (PAF). Life Sci 2007;81:210-7.
15. de Moura SA, Ferreira MA, Andrade SP, Reis ML, Noviello Mde L, Cara DC. Brazilian green propolis inhibits inflammatory angiogenesis in a murine sponge model. Evid Based Complement Alternat Med 2011;2011:182703.
16. Campos PP, Bakhle YS, Andrade SP. Mechanisms of wound healing responses in lupus-prone New Zealand White mouse strain. Wound Rep Reg 2008;16:416-24.
17. Hlkatky L, Hahnfeldt P, Folkman J. Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us. J Natl Cancer Inst 2002;94:883-93.
18. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989;246:1306-9.
19. Holderfield MT, Hughes CC. Crosstalk between vascular endothelial growth factor, notch, and transforming growth factor-beta in vascular morphogenesis. Circ Res 2008;102:637-52.
20. Bonanno E, Iurlaro M, Madri JA, Nicosia RF. Type IV collagen modulates angiogenesis and neovessel survival in the rat aorta model. In Vitro Cell Dev Biol Anim 2000;36:336-40.
21. Al-Harbi MM, Qureshi S, Ahmed MM, Raza M, Baig MZ, Shah AH. Effect of camel milk on the cytological and biochemical changes induced by cyclophosphamide in mice. J Ethnoparmacol 1996;52:129-37.
22. Khorshid FA, Moshref SS. In vitro anticancer agent, I-Tissue culture study of human lung cancer cells A549. II-Tissue culture study of mice leukemia cells L1210. Int J Cancer Res 2006;2:330-44.
23. Al-Yousef N, Gaafar A, Al-Otaibi B, Al-Jammaz I, Al-Hussein K, Aboussekhra A. Camel milk components display anti-cancer properties in vitro. J Ethnoparmacol 2012;143:819-25.
24. Belo AV, Barcelos LS, Ferreira MAND, Teixeira MM, Andrade SP. Inhibition of inflammatory angiogenesis by distant subcutaneous tumor in mice. Life Sci 2004;74:2827-37.
25. Bergheim I, Luyendyk JP, Steele C, Russell GK, Guo L, Roth RA, et al. Metformin prevents endotoxin induced liver injury after partial hepatectomy. J Pharmacol Exp Ther 2006;316:1053-61.
26. Yamaoka M, Masaki T, Sudo K, Shino A, Fujita T. Acceleration of wound healing by recombinant human basic fibroblast growth factor in a rat sponge-implantation model. Jpn J Inflamm 1991;11:65-72.
27. Dvorak HF. Vascular permeability factor/Vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J Clin Oncol 2002;21:4368-80.
28. Plouet J, Schilling J, Gospodarowicz D. Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT20 cells. EMBO J 1989;8:3801-6.
29. Nicosia RF, Nicosia SV, Smith M. Vascular endothelial growth factor, platelet-derived growth factor and insulin-like growth factor-1 promote rat aortic angiogenesis in vitro. Am J Pathol 1994;145:1023-9.
30. Phillips GD, Stone AM, Jones BD. Vascular endothelial growth factor (rhVEGF165) stimulates direct angiogenesis in the rabbit cornea. In Vivo 1995;8:961-5.
31. Tolentino MJ, Miller JW, Gragoudas ES. VEGF is sufficient to produce iris neovascularization and neovascular glaucoma in a non-human primate. Arch Ophthalmol 1996;114:964-70.
32. Connolly D, Olander J, Heuvelman D, Nelson R, Monsell R, Siegel N, et al. Human vascular permeability factor. Isolation from U937 cells. J Biol Chem 1989;264:20017-24.
33. Appleton I, Brown NJ, Willis D, Colville-Nash PR, Alam C, Brown JR, et al. The role of vascular endothelial growth factor in a milk chronic granulomatous tissue air pouch model of angiogenesis. J Pathol 1996;180:90-4.
34. Edward RH, Sarmenta SS, Hass GM. Stimulation of granulation tissue growth by tissue extracts; study by intramuscular wounds in rabbits. Arch Path 1960;69:286-302.
35. Andrade SP, Fan TPD, Lewis GP. Quantitative in vivo studies on angiogenesis in rat sponge model. Br J Exp Path 1987;68:755-6.
36. Andrade SP, Bakhle YS, Hart I, Piper PJ. Effects of tumor cells and vasoconstrictor responses in sponge implants in mice. Br J Cancer 1992;66:821-6.
37. Mendes JB, Rocha MA, Araújo FA, Moura SA, Ferreira MA, Andrade SP. Differential effects of rolipram on chronic subcutaneous inflammatory angiogenesis and on peritoneal adhesion in mice. Microvasc Res 2009;78:265-71.
38. Barcelos LS, Coelho AM, Russo RC, Guabiraba R, Souza AL, Bruno-Lima G Jr, et al. Role of the chemokines. CCL3/MIP-1α and CCL5/RANTES in sponge-induced inflammatory angiogenesis in mice. Microvasc Res 2009;78:148-54.
39. Zhu GG, Risteli L, Mäkinen M, Risteli J, Kauppila A, Stenbäck F. Immunohistochemical study of type I collagen and type I pN-collagen in benign and malignant ovarian neoplasms. Cancer 1995;75:1010-7.
40. Kauppila S, Stenbäck F, Risteli J, Jukkola A, Risteli L. Aberrant type I and type III collagen gene expression in human breast cancer in vivo. J Pathol 1998;186:262-8.
41. Huijbers IJ, Iravani M, Popov S, Robertson D, Al-Sarraj S, Jones C, et al. A role for fibrillar collagen deposition and the collagen internalization receptor endo180 in glioma invasion. PLoS One 2010;5:9808.
42. Condeelis J, Segall JE. Intravital imaging of cell movement in tumours. Nat Rev Cancer 2003;3:921-30.
43. Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 2009;139:891-906.